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Abstract 
Breastfeeding is associated with a lower risk of developing obesity during childhood and adulthood 
compared to feeding infant milk formula (IMF). Previous studies have shown that an experimental 
IMF (eIMF; comprising Nuturis®), programmed mouse pups for a lower body weight and fat mass 
gain in adulthood when challenged with a high-fat diet (HFD), compared to a control IMF (cIMF). 
Nuturis has a lipid composition and structure more similar to breastmilk. Here, the long-term effects 
were tested of a similar eIMF, but with an adapted lipid composition, and a cIMF, on body weight, 
glucose homeostasis, liver and adipose tissue. Nutrient composition was similar for the eIMF and 
cIMF; the lipid fractions comprised ~50% milkfat. C57BL/6JOlaHsd mice were fed cIMF or eIMF 
from postnatal (PN) day 16-42 followed by a HFD until PN168. Feeding eIMF versus cIMF in early 
life resulted in a lower body weight (-9%) and body fat deposition (-14%) in adulthood (PN105). 
The effect appeared transient, as from PN126 onward, after 12 weeks HFD, eIMF-fed mice caught 
up on controls and body and fat weights became comparable between groups. Glucose and energy 
metabolism were similar between groups. At dissection (PN168), eIMF-fed mice showed larger 
(+27%) epididymal fat depots and a lower (-26%) liver weight without clear morphological 
aberrations. Our data suggest the size and coating but not the lipid composition of IMF fat globules 
underlies the programming effect observed. Prolonged exposure to a HFD challenge partly 
overrules the programming effect of early diet. 
 
Introduction 
Breastfeeding is epidemiologically associated with a lower incidence in childhood and adulthood 
obesity, compared to infant milk formula (IMF)-feeding (1). Breastfeeding is also associated with 
lower blood pressure and lower plasma cholesterol levels in adulthood (2, 3). The nutritional 
composition of human milk (HM) is mimicked in IMF. However, mimicking fat emulsification is 
not yet possible. Fat in HM is dispersed in particles (5 µm diameter) enveloped by a trilayered milk 
fat globule membrane, composed mainly of phospholipids and cholesterol (4). In contrast, standard 
IMF fat globules are much smaller (0.1 µm diameter) and coated with surface-adhering proteins (4, 
5). Most likely the physicochemical structure (size and coating) of lipid globules in HM serves a 
biological purpose (4-8). An experimental IMF (eIMF; Nuturis®) was developed comprising large 
(mode diameter 3-5 µm) phospholipid-coated lipid globules similar in size to those in HM (4, 6). 
Feeding mice an eIMF-based diet in early life, compared to standard control IMF (cIMF), resulted 
in a lower body weight and lower fat mass accumulation when fed a high-fat diet (HFD) challenge 
diet into adulthood (6, 9, 10). The underlying mechanism of this effect on fat deposition of eIMF 
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To confirm and extend previous observations on eIMF programming effects in mouse pups, we 
used a similar paradigm, and determined the possible long-term effects of early-life eIMF exposure 
on body weight accrual, glucose homeostasis, and liver and adipose tissue attributes. We tested the 
hypothesis that the size and coating of lipid globules, and not the composition, underlies the initial 
programming effect observed. We therefore compared the cIMF and the eIMF with similar lipid 
compositions. 
 
Materials and methods 
Animals and Study design Experimental procedures were approved by an external independent 
animal experiment committee (Central Animal Experiments Committee, The Netherlands), and 
complied with the principles of good laboratory animal care following the EU-directive for the 
protection of animals used for scientific purposes. This study was conducted in accordance with 
institutional guidelines for the care and use of laboratory animals established by the Ethics 
Committee for Animal Experimentation of the University of Groningen (NVWA 10500) in full 
compliance to the European Directive 2010/63/EU for the use of animals for scientific purposes. All 
animals were kept in the same temperature-controlled room (21±1°C, 55±10% humidity, lights on 
8AM-8PM) in type 1L (360 cm²) polysulfone cages bearing stainless-steel wire covers (UNO BV, 
the Netherlands), with wood shaving bedding, Enviro-dri® (TecniLab, The Netherlands) and 
cardboard rolls. All mice were handled by the same researcher. Virgin C57BL/6JOlaHsd breeders 
(11M, 22F) 12 weeks of age, Envigo, The Netherlands) were mated (6) in 2F+1M couples. Males 
were removed from couples after 2 d. Pregnancy was confirmed by a >2 g increase in body weight 
after 1 week, and occurred at ~66% efficiency. Delivery day was recorded as postnatal day (PN) 0. 
Pups were randomized between dams, and litters were culled to 4M+2F on PN2, weaned at PN21, 
and diets provided as freshly prepared dough balls (40% water) from PN16 to PN42 (6, 9). 
Randomization was not performed as the programming diets were visually distinct. Breeders and 
female offspring were terminated (CO2) at weaning, in compliance with the AVMA Guidelines for 
the Euthanasia of Animals. From PN42 onward, male offspring was pair-housed with siblings and 
fed a high-fat diet (HFD, 45%en fat, D12451 Research Diets Inc. USA) and tap water ad libitum 
until dissection on PN168. Females were not used, as they are protected against HFD-induced 
metabolic changes (11). Glucose tolerance and calorimetry was assessed at PN133 and PN154, 
respectively (Fig 1). Programming diets Two IMF powders (Nutricia Cuijk B.V., Cuijk, the 
Netherlands) were tested. The IMF powders had a similar macro- and micronutrient content (Table 
1); both lipid moieties comprised about 50% vegetable oil and 50% milkfat (Table 1) and had a 
similar fatty acid profile (Table 2). cIMF comprised fat globules with a volume mean diameter 
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µm, explained in more detail elsewhere (4). IMF powders (283 g/kg feed) were supplemented with 
protein and carbohydrate (Ssniff Spezialdiäten GmbH, Soest, Germany) to obtain AIN-93G-
compliant
 
diets, with a fat moiety derived entirely from IMF (12). 
Body composition Lean and fat mass was quantified by time-domain nuclear magnetic resonance 
(LF90II, Bruker Optics, Billerica, MA), not requiring fasting or anesthesia. Glucose, insulin and 
pyruvate tolerance tests Mice were fasted 6, 6 and 4 hours for the glucose, pyruvate and insulin 
tolerance test (GTT, PTT, ITT), respectively. GTT (i.p. 13.9 µmol glucose/g BW), ITT (i.p. 0.5 mU 
insulin/g BW) and PTT (i.p. 28.4 µmol pyruvate/g BW) were performed as previously described 
(13). Calorimetry Mice were single-housed in a Comprehensive Laboratory Animal Monitoring 
System (Phenomaster, TSE systems GmbH, Bad Homburg, Germany) at PN154 for 4 days as 
previously described (14). Termination Mice were anaesthetized (isoflurane/O2) after a 4-h fasting 
period (during light phase) and sacrificed by heart puncture; a terminal blood sample was drawn. 
Liver, epididymal, inguinal, perirenal and interscapular fat was obtained and weighed. Assays 
Plasma was analyzed using the V-PLEX Proinflammatory Panel 1 (mouse) kit (K15048D), Mouse 
Adiponectin Kit (K152BXC), Mouse Leptin Kit (K152BYC), Mouse MCP-1 Ultra-Sensitive Kit 
(K152AYC), Mouse/Rat Total Active GLP-1, Insulin, Glucagon Kit (K15171C) and the Mouse/Rat 
Resistin Kit (K152FNC). Analyses were performed according to the manufacturer’s instructions. 
Kits were purchased from MSD (Meso Scale Diagnostics LLC, USA). Blood glucose was measured 
using a OneTouch Select Plus (Lifescan Inc., USA). 
Liver fatty acyl chain profiling Cryogenically crushed liver was homogenized in Potter-Elvehjem 
tubes. Lipids were trans-methylated, extracted and analyzed by gas chromatography as previously 
described (15). 
Analysis of gene expression Gene expression was analyzed by quantitative real-time PCR as 
previously described (16). Cyclophilin and 36b4 were used as housekeeping genes for hepatic and 
adipose tissue gene expression respectively. Primer and TaqMan probe sequences are given in 
Suppl Table 1. 
Histological analysis A liver lobe and the left epididymal fat pad were formalin-fixed and paraffin-
embedded, sectioned, H&E stained. Liver slices were scored blindly for steatosis, NAS (17), 
ballooning (18) and findings were reviewed by a certified veterinary pathologist (AdB). Liver 
sections were stained for the proliferation marker Ki-67 as previously described (19). Histological 
scoring of Ki-67 was performed in 5 separate x40 fields by a single assessor. Binucleation and 
karyomegaly was assessed as described (20). Adipose tissue sections were quantified using 
Adiposoft (21). Adipose tissue was assessed for the presence of inflammatory foci (‘crown-like 
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Statistical analysis Statistics were performed using GraphPad Prism 5 (GraphPad Software, USA) 
and SPSS 23 (SPSS Inc., USA). Data are plotted as Tukey box-and-whisker plots unless stated 
otherwise. Group sizes were calculated (23) using a relevant and most varied value, previously 
obtained (plasma IL-6) (6); expected difference 12 ng/L, spread 10 ng/L, alpha 0.05, beta 0.80. 




eIMF transiently lowers body weight gain on HFD 
An initially comparable rapid weight gain (PN42-56) preceded a period (PN63-119) of lower 
weight gain in eIMF compared to cIMF (-9% on average, p<0.05). From PN126 onwards, weights 
between groups were no longer significantly different (Fig. 2A). Fat and lean mass were similar at 
PN42. At PN72, 105 and 126, fat mass was substantially lower in eIMF compared to cIMF (-10%, -
14%, -7%; p<0.01), and lean mass was slightly lower (-4%, -8%, -6%; p<0.01; Fig 2B) 
respectively. Fat percentage and lean percentage were similar at PN42. The average fat percentage 
(PN42-126) was not-significantly lower in eIMF (-5%; p=0.07), whereas lean percentage was not-
significantly higher in eIMF (+3%; p=0.08; Fig. 2C). To assess whether later-life effects were due 
to differences in growth in early life, we measured body weight from weaning, which was similar 
between groups, and body composition at PN28 and 35; which was similar. At PN147-154, daily 
food intake was on average 14% lower in eIMF (p=0.08, Fig. 2F), correlating with the calculated 
slope of prior weight gain (PN42-PN147, Spearman’s rank-order, rs = 0.6, p<0.01). Energy 
expenditure (Fig. 2G), and locomotor activity (Fig. 2H) were similar. At PN133 the ipGTT time 
course (Fig 2I) and AUC (2.1±0.6 versus 1.9±0.4 M·min) was similar between groups. The ipITT 
(PN140) and ipPTT (PN147) AUCs (1.4±0.3 versus 1.2±0.2 and 1.6±0.5 versus 1.4±0.4 M·min, 
respectively) were similar. 
 
eIMF-programmed mice have a lower liver weight independent of body weight 
Upon dissection at PN168, we noted that eIMF-fed mice had lower liver weights (Fig 3A; -25%; 
p<0.05) and a lower liver-to-body weight ratio (Fig 3B; -23%; p<0.01). The lower liver weight was 
not related to triglyceride (TG) levels, which showed moderate variability (Fig 3C). Liver protein 
(mg/g liver) was higher in the eIMF group (+9%; p<0.05), whereas total liver protein was lower in 
eIMF (mg/liver; -20%; p<0.05, Fig 3D). Gene expression markers for hepatic de novo lipogenesis 
(Fasn, Scd1, Acaca, Pparg) and fatty-acid oxidation (Pparα, Pgc1α, Cpt1) (Fig 3E) were similar. 
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Histological analysis (Fig 3H, Table 3) showed that steatosis tended to be higher in cIMF (70 ± 17 
versus 57 ± 32 %, steatosis grade 2.5 ± 0.5 versus 2.1 ± 1.0), but this difference did not reach 
statistical significance. Microvesicular steatosis was more frequent than macrovesicular steatosis in 
both groups and typically showed a zonal distribution characterized by central microvesicular 
steatosis with mild to moderate mid-zonal (occasionally extending to portal) macrovesicular 
steatosis. Lobular inflammation and ballooning was similar between groups. NAFLD score, mostly 
influenced by steatosis, tended to be higher in cIMF but did not reach statistical significance. 
Varying degrees of biliary / oval cell hyperplasia were seen in almost all mice. The mitotic index 
(Ki-67) was similar between groups. Binuclear hepatocyte counts in the central and mid/portal 
region were similar between groups. Hepatic fatty acyl chain ratios representing lipid-related 
enzymatic activity (24, 25) were similar between groups.  
 
Body fat storage was shifted by eIMF programming without affecting adult adipokine levels 
At PN168 we analyzed adipose tissue and plasma adipokines (Fig 4). Epididymal fat mass was 
larger in eIMF (Fig 4A; +27%; p<0.01). Inguinal fat mass was similar. Interscapular brown fat mass 
tended to be smaller in eIMF (-10%; p=0.06). The median epididymal adipocyte diameter tended to 
be higher in eIMF (Fig 4B; +11%; p=0.08). The median perirenal and inguinal adipocyte diameter 
(Fig 4B) was comparable. Gene expression for Ppar-γ, Fas, Fabp4, Tnf-α and Cd68 was similar 
between groups (Fig 4C). The assessed adipokines (leptin, adiponectin, resistin, Mcp-1, Tnf-α and 
Il-6), glucostatic hormones (insulin and glucagon), and cytokines (Ifnγ, Cxcl-1, Il-1β, Il-2, Il-5 and 
Il-10) were similar (Fig 4D). Crown-like structures in adipose tissue were seen in all cIMF and in 
10/11 eIMF mice, but tended to occur more often in cIMF (Fig 4E; epididymal 8.0±8.8 versus 
5.0±6.9; perirenal 9±10 versus 10±19). This difference was not statistically significant.  
 
 Discussion 
In the present work, we studied the long-term effects of early life exposure (PN16-42) to 
eIMF versus cIMF on body weight and body compositional development into adulthood when 
animals were continuously challenged to a HFD, as well as its effects on liver and adipose tissues 
size and function (Fig 1). Previously, eIMF with a different lipid composition was found to program 
mice for a lower body fat accumulation when they were challenged with a HFD up to PN126 (6). In 
the current study, IMFs had a different lipid composition and HFD exposure was extended to 
PN168. Similar programming effects were seen up to PN126, whereafter differences in body weight 
and composition disappeared upon continued HFD exposure (Fig 2). Interestingly, food intake, 
despite high variability, tended to be lower at PN154 in eIMF-fed mice (Fig. 2), strongly correlating 
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part, be attributed to differences in food intake. The effects observed being transient may indicate 
that the programming response, i.e., the initial lower fat accumulation in adipose stores, can be 
overruled by a strong and persistent dietary challenge. In addition, our study suggests these 
programming effects, due to early life eIMF exposure, occurred regardless of the lipid composition 
of the fat globules, and is rather caused by the physicochemical structure of the lipids, i.e., globule 
size and phospholipid coating (10). In humans and mammals, the amount of lipids in (mature) milk, 
despite highly variable diets, is remarkably stable (26, 27). The size of milk fat globules, as well as 
the milk TG content, seem to be tightly regulated and species-specific (28), and greatly impact the 
absorption kinetics of breast milk lipids (29, 30). Testing eIMF (large and phospholipid coated fat 
globules) versus cIMF (small, uncoated fat globules) in adult men resulted in a different 
postprandial response upon a single bolus intake: an earlier postprandial glucose and insulin time-
to-peak, an earlier non-esterified fatty acids (NEFA) time-to-nadir, and a later cholecystokinin time 
course (30). We hence speculate that fat globule size and phospholipid coating programs metabolic 
and tissue development induced by differential lipid uptake kinetics or post-absorptive lipid 
trafficking or tissue partitioning. Lipid uptake kinetics of eIMF, compared to cIMF, are likely to be 
more comparable to breastmilk. 
Early-life feeding with eIMF compared to cIMF lowered liver weight in later life 
independent of body weight (Fig 3). The difference was not explained by mitotic index, or the 
degree of polyploidization. Hepatic triglyceride content had moderate variability without clear 
correlation with other parameters. Possibly the early-life diet primed hepatic tissue for a different 
response to a HFD challenge, resulting in a differential tissue growth. It is also possible, however, 
that the transient difference in body weight (or adipose tissue development) triggers a difference in 
liver size. Previously, a non-significantly higher liver weight had been seen in cIMF compared to 
eIMF and to an unchallenged control group (9). Additionally, a higher liver weight was seen upon 
early-life feeding with an IMF containing small compared to large lipid globules and challenging 
with a HFD (10). We hypothesize that postnatal liver development was changed due to a difference 
in post-absorptive lipid handling and trafficking. As mentioned earlier, eIMF is more rapidly 
absorbed compared to cIMF in adult men (30). In addition, a gavage of breastmilk, compared to 
standard formula, leads to a more rapid chylomicron (CM) production and a more rapid absorption 
of palmitic, arachidonic and docosahexaenoic acid in adult rats (29). Rapid absorption of protein-
coated fat results in 3-fold larger CM diameter (31). However, we believe rapid lipid absorption 
only leads to larger CM when enteral phospholipid supply is limited, necessitating higher volume-
to-surface area ratios (32). In contrast, CM diameter is lowered by biliary phospholipids (32). It is 
possible that breastmilk, and likewise eIMF, is rapidly absorbed and produces smaller CM than 
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IMF with large globules but lacking phospholipids does not program mice for less fat accrual in 
later life (10), adds weight to this notion. CM size and number affect the plasma half-life, as smaller 
particles have a larger relative surface area available to enzymes (33, 34), and are more quickly 
removed from the plasma via liver sieving (35). CM produced upon eIMF or HM ingestion are 
expected to have a different fractional clearance rate than CM upon cIMF ingestion. It is tempting 
to speculate that a more rapid absorption plus utilization, opposed to storage, of breastmilk and 
eIMF derived lipids in early life programs metabolism and fat accumulation capacity towards an 
advantageous trait for later-life health. 
The effect on fat pad weights and adipocyte diameter was independent of body weight and 
composition (Fig 4). Previous studies showed that at PN98 the epididymal fat pad was smaller in 
eIMF-fed mice (9, 10), whereas this difference between test groups had disappeared at PN126 (6). 
We observed a higher epididymal fat mass in eIMF at PN168, indicating a differential fat 
distribution in eIMF vs. cIMF, as the perirenal and inguinal fat pad were similar in mass. 
Counterintuitively, the larger epididymal fat pads seen in eIMF did not result in lower levels of 
adiponectin and did result in higher levels of inflammatory markers (Tnf-α, Il-6), Mcp-1, or resistin 
(Fig 4) as typically seen with larger visceral adipose tissue (36). Interestingly, we found no effect on 
glucose metabolism and homeostasis (Fig 2I). Previously, eIMF-fed mice had lower plasma leptin, 
resistin, glucose and HOMA-IR at PN126 (6), likely related to the lower fat mass. A lower fat 
accrual rate, transiently seen in eIMF, is advantageous to metabolic health. However, given the 
observed minor effects on adipose tissue at PN168, we think it is unlikely that adipose tissue 




The present study shows that feeding a postnatal diet containing large phospholipid-coated 
lipid globules has transient effects on body fat accrual during prolonged exposure to HFD. These 
effects are limited in strength and robustness and can be overruled by (too) strong environmental 
features, such as continued high-fat diet feeding. Our findings indicate the robustness and the limits 
of early-life programming due to eIMF exposure in the employed mouse model. The observed 
programming effects are hypothesized to be due to a difference in fat absorption, and/or post-
absorptive handling and trafficking in the body. 
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Table 1. Nutrient composition of the programming diets (PN16-42) and the high fat diet (PN42-168). *: all in g/kg 
  Control IMF Experimental IMF HFD 
Carbohydrate *  609 618 396 
Mono/di-saccharides 225 235 172.8 
 Glucose  3.7 3.4 - 
 Lactose 134 144 - 
 Sucrose 85 85 172.8 
 Other sugars 2.6 2.4 - 
Polysaccharides *  380 380 172.8 
 Maltodextrin 101 101 100 
 Corn starch 280 280 72.8 
 Other 0.84 0.68 - 
Fiber *  49.0 48.2 50 
 Cellulose 32.0 32.0 50 
 Fructo-oligosaccharides 1.7 1.4 - 
 Galacto-oligosaccharides 15.3 14.3 - 
Lipids *  77.2 70.6 203 
 Vegetable fat 37.5 32.9 25 
 Milkfat 38.6 36.7 - 
 Other animal fat 1.1 0.98 - 
 Lard - - 177.5 
 Phospholipids 0.084 1.1 - 
 Cholesterol 0.12 0.12 0.20 
Protein *  199 198 200 
 Whey 17.6 16.5 - 
 Casein 181 181 200 
Particle size D[4,3] (µm) 0.81 ± 0.2 6.8 ± 0.2 - 
 D[3,2] (µm) 0.43 ± 0.004 0.86 ± 0.1 - 
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Table 2. Fatty acid composition of the programming diets (PN16-42). *: all in FA weight% 
  Control IMF Experimental IMF 
Saturated*  44 42 
 14:0 8.9 7.1 
 16:0 26 25 
 18:0 7.8 8.9 
 20:0 0.28 0.32 
 22:0 0.27 0.39 
 24:0 0.17 0.26 
 26:0 0.032 0.039 
Mono unsaturated*  36 39 
 16:1ω7 1.2 1.1 
 18:1ω7 1.9 1.9 
 18:1ω9 33 35 
 20:1ω9 0.38 0.42 
 22:1ω9 0.080 0.13 
 24:1ω9 0.053 0.074 
Polyunsaturated*  20 19 
 ω-3 species 3.4 3.4 
 18:3ω3 2.8 2.8 
 20:5ω3 0.12 0.12 
 22:6ω3 0.38 0.38 
 22:5ω3 0.090 0.099 
 ω-6 species 16 16 
 18:2ω6 16 15 
 18:3ω6 0.050 trace 
 20:4ω6 0.44 0.43 
 20:3ω6 0.091 0.12 
 20:2ω6 0.046 trace 
  ω-6 /  ω-3 ratio 4.8 4.7 
 20:3ω9 0.38 0.42 
 
Table 3. Hepatic histological scoring and fatty-acid ratios of mice programmed with cIMF (n=12) or eIMF (n=11) and 
subsequently challenged to a HFD.  Values represent means ± SD. 
   Control IMF Experimental IMF 
   mean SD mean SD 
Steatosis Steatosis grade  2.5 0.5 2.1 1.0 
 Steatosis % 70 17 57 32 
 Location steatosis  12/12 central  8/10 central;  
2/10 azonal 
 
 Hepatocytes with micro- vs.  
macrovesicular steatosis 
% 78 9 78 8 
 Ballooning   Few, 2/12  Few, 2/11  
 Lobular inflammation  1.0 0.5 1.1 0.6 
 NAFLD score  3.7 0.8 3.3 1.5 
 Biliary/oval cell hyperplasia  1.4 0.8 1.5 0.5 
Mitosis Mitotic index % 4.3 2.0 4.3 2.7 
 Binuclear cells per field n 4.5 2.1 4.7 3.3 
 Central binuclear cells n 4.7 3.5 4.1 3.6 
 Mid/portal binuclear cells n 4.4 1.7 5.2 3.7 
Fatty acyl  
chain ratios 
 ω-6 /  ω-3  6.3 0.6 6.2 0.72 
16:1ω7 / 16:0  0.13 0.021 0.12  0.037 
 18:1 / 18:0  8.5 2.6 7.9 2.6 
 18:1ω9 / 18:0  7.8 2.4 7.3 2.4 
 18:1 / 16:1  13 1.9 14 2.8 
 22:4ω6 / 18:2ω6  0.029 0.01 0.025 0.006 
 20:4ω6 / 20:3ω6  4.8 1.1 5.3 1.5 
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Fig 1. Study design from postnatal day (PN) 0 to 168 (n=12).  
 
Fig 2. Mice programmed with eIMF and challenged with a high-fat diet showed a transient lower body weight, 
lean mass and fat mass compared to animals programmed with cIMF . Body weight (A), fat & lean mass (C) are 
expressed in absolute weights. The percentage of fat & lean mass (C) are expressed as % of body weight. Early-life 
body weight (D) and fat & lean mass (E) are expressed in absolute weights.  Food intake (F), energy expenditure (G), 
and locomotor activity (H) was measured 3 times 24 h from PN154. Glucose tolerance at PN133 is shown as AUC (I). 
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Fig 3. Mice programmed with eIMF compared to cIMF showed a lower liver weight with a concurrent higher 
protein content without a shift in fatty acyl chain profile. Dissection was performed at PN168. Liver weight (A) is 
expressed as wet weight. The liver to bodyweight ratio (B) is expressed as % of bodyweight. TG levels (C) are 
expressed per gram liver. Liver protein content (D) is expressed as mg per gram wet liver tissue. Hepatic mRNA levels 
(E) were normalized to cyclophilin. Fatty acyl chain profile is expressed as fold change compared to cIMF (G). Liver 
histology (H&E; F) showed a zonal distribution characterized by central microvesicular steatosis with mild to moderate 
mid-zonal macrovesicular steatosis. Bar: 250µm, inset bar: 100µm. n=11-12; Tukey boxplots and scatter plots; ** 
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Fig 4. Mice programmed with eIMF compared to cIMF showed an higher visceral adipose tissue weight and 
adipocyte cell diameter. Epididymal (EPI) visceral, inguinal (ING) subcutaneous and interscapular (BAT) brown 
adipose tissue (A) are expressed as absolute weights. EPI, perirenal (PERI) and ING (B) adipocyte diameter was 
calculated (Adiposoft) and expressed as equivalent diameter. The epididymal fat gene expression (C) was normalized to 
36b4 and shown as fold change. Plasma adipokines, glucostatic hormones and cytokines are expressed as pg/ml (D). 
Adipose (epididymal depot) pathology (E) characterized by crown-like structures composed of macrophages and other 
mixed inflammatory cells with lipofuscin (*) surrounding a necrotic adipocyte, bar: 100 µm, inset bar: 50 µm. Tukey 
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